{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:36:44Z","timestamp":1794724604119,"version":"4.9.1"},"reference-count":212,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA284209"],"award-info":[{"award-number":["U01CA284209"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-026-01529-5","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:04:23Z","timestamp":1781514263000},"page":"1266-1281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adiposity and cancer: epidemiology, mechanisms and future perspectives"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9229-2589","authenticated-orcid":false,"given":"Eleanor L.","family":"Watts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Gonzalez-Feliciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9060-008X","authenticated-orcid":false,"given":"Nilanjan","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8169-1661","authenticated-orcid":false,"given":"Steven C.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"1529_CR1","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 403, 1027\u20131050 (2024)."},{"key":"1529_CR2","unstructured":"Global Burden of Disease 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet 405, 813\u2013838 (2025)."},{"key":"1529_CR3","doi-asserted-by":"publisher","unstructured":"Watts, E. L., Gonzalez-Feliciano, A., Gunter, M. J. & Chatterjee, N. Adiposity and cancer: systematic review and meta-analysis. Nat. Metab. https:\/\/doi.org\/10.1038\/s42255-026-01542-8 (2026).","DOI":"10.1038\/s42255-026-01542-8"},{"key":"1529_CR4","unstructured":"WCRF\/AICR. Judging the evidence. https:\/\/www.wcrf.org\/wp-content\/uploads\/2024\/11\/judging-the-evidence.pdf (2018)."},{"key":"1529_CR5","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan, B. et al. Body fatness and cancer \u2014 viewpoint of the IARC Working Group. N. Engl. J. Med. 375, 794\u2013798 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1529_CR6","doi-asserted-by":"publisher","first-page":"101034","DOI":"10.1016\/j.lanepe.2024.101034","volume":"45","author":"M Sun","year":"2024","unstructured":"Sun, M. et al. Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study. Lancet Reg. Health Eur. 45, 101034 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"1529_CR7","unstructured":"GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1160\u20131203 (2020)."},{"key":"1529_CR8","doi-asserted-by":"publisher","first-page":"e2420902122","DOI":"10.1073\/pnas.2420902122","volume":"122","author":"A McGrosky","year":"2025","unstructured":"McGrosky, A. et al. Energy expenditure and obesity across the economic spectrum. Proc. Natl Acad. Sci. USA 122, e2420902122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1529_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff, A. M. et al. Tirzepatide once weekly for the treatment of obesity. N. Engl. J. Med. 387, 205\u2013216 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1529_CR10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","volume":"397","author":"M Davies","year":"2021","unstructured":"Davies, M. et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet 397, 971\u2013984 (2021).","journal-title":"Lancet"},{"key":"1529_CR11","doi-asserted-by":"publisher","first-page":"bnaa004","DOI":"10.1210\/endrev\/bnaa004","volume":"41","author":"M Bl\u00fcher","year":"2020","unstructured":"Bl\u00fcher, M. Metabolically healthy obesity. Endocr. Rev. 41, bnaa004 (2020).","journal-title":"Endocr. Rev."},{"key":"1529_CR12","first-page":"1","volume":"854","author":"WHO Expert Committee.","year":"1995","unstructured":"WHO Expert Committee. Physical status: the use and interpretation of anthropometry. World Health Organ. Tech. Rep. Ser. 854, 1\u2013452 (1995).","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"1529_CR13","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","volume":"359","author":"T Pischon","year":"2008","unstructured":"Pischon, T. et al. General and abdominal adiposity and risk of death in Europe. N. Engl. J. Med. 359, 2105\u20132120 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1529_CR14","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3945\/ajcn.2009.27598","volume":"89","author":"SC Moore","year":"2009","unstructured":"Moore, S. C. Waist versus weight: which matters more for mortality? Am. J. Clin. Nutr. 89, 1003\u20131004 (2009).","journal-title":"Am. J. Clin. Nutr."},{"key":"1529_CR15","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3945\/ajcn.2008.26698","volume":"89","author":"KM Flegal","year":"2009","unstructured":"Flegal, K. M. & Graubard, B. I. Estimates of excess deaths associated with body mass index and other anthropometric variables. Am. J. Clin. Nutr. 89, 1213\u20131219 (2009).","journal-title":"Am. J. Clin. Nutr."},{"key":"1529_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08820-6","volume":"21","author":"S Christakoudi","year":"2021","unstructured":"Christakoudi, S., Tsilidis, K. K., Evangelou, E. & Riboli, E. Association of body-shape phenotypes with imaging measures of body composition in the UK Biobank cohort: relevance to colon cancer risk. BMC Cancer 21, 1106 (2021).","journal-title":"BMC Cancer"},{"key":"1529_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/epirev\/mxm012","volume":"29","author":"B Caballero","year":"2007","unstructured":"Caballero, B. The global epidemic of obesity: an overview. Epidemiol. Rev. 29, 1\u20135 (2007).","journal-title":"Epidemiol. Rev."},{"key":"1529_CR18","doi-asserted-by":"crossref","unstructured":"Swinburn, B. A. et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 378, 804\u2013814 (2011).","DOI":"10.1016\/S0140-6736(11)60813-1"},{"key":"1529_CR19","doi-asserted-by":"crossref","unstructured":"Swinburn, B. A. et al. The global syndemic of obesity, undernutrition, and climate change: The Lancet Commission report. Lancet 393, 791\u2013846 (2019).","DOI":"10.1016\/S0140-6736(19)30310-1"},{"key":"1529_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ajcn\/86.2.353","volume":"86","author":"SA Lear","year":"2007","unstructured":"Lear, S. A. et al. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am. J. Clin. Nutr. 86, 353\u2013359 (2007).","journal-title":"Am. J. Clin. Nutr."},{"key":"1529_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/joim.13082","volume":"288","author":"H Yaghootkar","year":"2020","unstructured":"Yaghootkar, H., Whitcher, B., Bell, J. D. & Thomas, E. L. Ethnic differences in adiposity and diabetes risk \u2013 insights from genetic studies. J. Intern. Med. 288, 271\u2013283 (2020).","journal-title":"J. Intern. Med."},{"key":"1529_CR22","doi-asserted-by":"publisher","first-page":"e0155478","DOI":"10.1371\/journal.pone.0155478","volume":"11","author":"WR Scott","year":"2016","unstructured":"Scott, W. R. et al. Investigation of genetic variation underlying central obesity amongst South Asians. PLoS ONE 11, e0155478 (2016).","journal-title":"PLoS ONE"},{"key":"1529_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-020-01026-2","volume":"17","author":"I Marete","year":"2020","unstructured":"Marete, I. et al. Regional trends in birth weight in low- and middle-income countries 2013-2018. Reprod. Health 17, 176 (2020).","journal-title":"Reprod. Health"},{"key":"1529_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.soard.2009.07.003","volume":"6","author":"M Martin","year":"2010","unstructured":"Martin, M., Beekley, A., Kjorstad, R. & Sebesta, J. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg. Obes. Relat. Dis. 6, 8\u201315 (2010).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"1529_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-publhealth-031816-044604","volume":"38","author":"ND Ford","year":"2017","unstructured":"Ford, N. D., Patel, S. A. & Narayan, K. M. V. Obesity in low- and middle-income countries: burden, drivers, and emerging challenges. Annu. Rev. Public Health 38, 145\u2013164 (2017).","journal-title":"Annu. Rev. Public Health"},{"key":"1529_CR26","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/s41591-026-04219-7","volume":"32","author":"H Fink","year":"2026","unstructured":"Fink, H. et al. Global and regional cancer burden attributable to modifiable risk factors to inform prevention. Nat. Med. 32, 1306\u20131315 (2026).","journal-title":"Nat. Med."},{"key":"1529_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","volume":"400","author":"KB Tran","year":"2022","unstructured":"Tran, K. B. et al. The global burden of cancer attributable to risk factors, 2010\u201319: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400, 563\u2013591 (2022).","journal-title":"Lancet"},{"key":"1529_CR28","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/S2468-2667(18)30267-6","volume":"4","author":"H Sung","year":"2019","unstructured":"Sung, H., Siegel, R. L., Rosenberg, P. S. & Jemal, A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health 4, e137\u2013e147 (2019).","journal-title":"Lancet Public Health"},{"key":"1529_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s13679-020-00398-7","volume":"9","author":"CV Anekwe","year":"2020","unstructured":"Anekwe, C. V. et al. Socioeconomics of obesity. Curr. Obes. Rep. 9, 272\u2013279 (2020).","journal-title":"Curr. Obes. Rep."},{"key":"1529_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41416-020-01038-6","volume":"124","author":"VA Zavala","year":"2021","unstructured":"Zavala, V. A. et al. Cancer health disparities in racial\/ethnic minorities in the United States. Br. J. Cancer 124, 315\u2013332 (2021).","journal-title":"Br. J. Cancer"},{"key":"1529_CR31","unstructured":"Hales, C. M., Carroll, M. D., Fryar, C. D. & Ogden, C. L. Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018. National Center for Health Statistics, CDC https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db360.htm (2020)."},{"key":"1529_CR32","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1158\/1055-9965.EPI-20-0358","volume":"29","author":"MCS Bissell","year":"2020","unstructured":"Bissell, M. C. S. et al. Breast cancer population attributable risk proportions associated with body mass index and breast density by race\/ethnicity and menopausal status. Cancer Epidemiol. Biomarkers Prev. 29, 2048\u20132056 (2020).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1529_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/cancers10070235","volume":"10","author":"L Scarton","year":"2018","unstructured":"Scarton, L. et al. Pancreatic cancer related health disparities: a commentary. Cancers 10, 235 (2018).","journal-title":"Cancers"},{"key":"1529_CR34","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/jnci\/djs346","volume":"104","author":"CA Doubeni","year":"2012","unstructured":"Doubeni, C. A. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J. Natl Cancer Inst. 104, 1353\u20131362 (2012).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR35","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10555-022-10054-2","volume":"41","author":"Z Fang","year":"2022","unstructured":"Fang, Z. & Giovannucci, E. L. The timing of adiposity and changes in the life course on the risk of cancer. Cancer Metastasis Rev. 41, 471\u2013489 (2022).","journal-title":"Cancer Metastasis Rev."},{"key":"1529_CR36","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/jnci\/djac061","volume":"114","author":"D Mariosa","year":"2022","unstructured":"Mariosa, D. et al. Body size at different ages and risk of 6 cancers: a Mendelian randomization and prospective cohort study. J. Natl Cancer Inst. 114, 1296\u20131300 (2022).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR37","doi-asserted-by":"publisher","first-page":"m1203","DOI":"10.1136\/bmj.m1203","volume":"369","author":"TG Richardson","year":"2020","unstructured":"Richardson, T. G., Sanderson, E., Elsworth, B., Tilling, K. & Smith, G. D. Use of genetic variation to separate the effects of early and later life adiposity on disease risk: Mendelian randomisation study. BMJ 369, m1203 (2020).","journal-title":"BMJ"},{"key":"1529_CR38","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1038\/s41591-025-03827-z","volume":"31","author":"RAJ Smit","year":"2025","unstructured":"Smit, R. A. J. et al. Polygenic prediction of body mass index and obesity through the life course and across ancestries. Nat. Med. 31, 3151\u20133168 (2025).","journal-title":"Nat. Med."},{"key":"1529_CR39","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jamasurg.2016.2317","volume":"151","author":"ML Maciejewski","year":"2016","unstructured":"Maciejewski, M. L. et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 151, 1046\u20131055 (2016).","journal-title":"JAMA Surg."},{"key":"1529_CR40","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s11695-019-04368-4","volume":"30","author":"K Zhang","year":"2020","unstructured":"Zhang, K., Luo, Y., Dai, H. & Deng, Z. Effects of bariatric surgery on cancer risk: evidence from meta-analysis. Obes. Surg. 30, 1265\u20131272 (2020).","journal-title":"Obes. Surg."},{"key":"1529_CR41","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1001\/jama.2022.9009","volume":"327","author":"A Aminian","year":"2022","unstructured":"Aminian, A. et al. Association of bariatric surgery with cancer risk and mortality in adults with obesity. JAMA 327, 2423\u20132433 (2022).","journal-title":"JAMA"},{"key":"1529_CR42","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/jnci\/djz226","volume":"112","author":"LR Teras","year":"2020","unstructured":"Teras, L. R. et al. Sustained weight loss and risk of breast cancer in women 50 years and older: a pooled analysis of prospective data. J. Natl Cancer Inst. 112, 929\u2013937 (2020).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR43","doi-asserted-by":"publisher","first-page":"pkz054","DOI":"10.1093\/jncics\/pkz054","volume":"3","author":"J Luo","year":"2019","unstructured":"Luo, J. et al. Intentional weight loss and obesity-related cancer risk. JNCI Cancer Spectr. 3, pkz054 (2019).","journal-title":"JNCI Cancer Spectr."},{"key":"1529_CR44","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding, J. P. H. et al. Once-weekly semaglutide in adults with overweight or obesity. N. Engl. J. Med. 384, 989\u20131002 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1529_CR45","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/jnci\/djae260","volume":"117","author":"L Wang","year":"2025","unstructured":"Wang, L., Wang, Q., Li, L., Kaelber, D. C. & Xu, R. Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data. J. Natl Cancer Inst. 117, 476\u2013485 (2025).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR46","doi-asserted-by":"publisher","first-page":"e078225","DOI":"10.1136\/bmj-2023-078225","volume":"385","author":"B Pasternak","year":"2024","unstructured":"Pasternak, B. et al. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study. BMJ 385, e078225 (2024).","journal-title":"BMJ"},{"key":"1529_CR47","doi-asserted-by":"publisher","first-page":"107401","DOI":"10.1016\/j.phrs.2024.107401","volume":"208","author":"G Figlioli","year":"2024","unstructured":"Figlioli, G. et al. Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: a systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 208, 107401 (2024).","journal-title":"Pharmacol. Res."},{"key":"1529_CR48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jamaoncol.2023.5573","volume":"10","author":"L Wang","year":"2024","unstructured":"Wang, L., Wang, W., Kaelber, D. C., Xu, R. & Berger, N. A. GLP-1 receptor agonists and colorectal cancer risk in drug-naive patients with type 2 diabetes, with and without overweight\/obesity. JAMA Oncol. 10, 256\u2013258 (2024).","journal-title":"JAMA Oncol."},{"key":"1529_CR49","doi-asserted-by":"publisher","first-page":"e2421305","DOI":"10.1001\/jamanetworkopen.2024.21305","volume":"7","author":"L Wang","year":"2024","unstructured":"Wang, L., Xu, R., Kaelber, D. C. & Berger, N. A. Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes. JAMA Netw. Open 7, e2421305 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1529_CR50","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1093\/jnci\/djaf163","volume":"117","author":"X Mao","year":"2025","unstructured":"Mao, X. et al. Association between glucagon-like peptidase 1 receptor agonist and obesity-related cancer in overweight or obese patients with type 2 diabetes: a nationwide cohort study. J. Natl Cancer Inst. 117, 2053\u20132061 (2025).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR51","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/jnci\/djaf212","volume":"117","author":"J Yarmolinsky","year":"2025","unstructured":"Yarmolinsky, J. & Gunter, M. J. GLP-1 receptor agonists: an emerging tool for obesity-related cancer prevention? J. Natl Cancer Inst. 117, 1966\u20131969 (2025).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR52","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/jnci\/djae021","volume":"116","author":"L O\u2019Connor","year":"2024","unstructured":"O\u2019Connor, L. et al. Association of metformin use and cancer incidence: a systematic review and meta-analysis. J. Natl Cancer Inst. 116, 518\u2013529 (2024).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR53","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jamaoncol.2025.2681","volume":"11","author":"H Dai","year":"2025","unstructured":"Dai, H. et al. GLP-1 receptor agonists and cancer risk in adults with obesity. JAMA Oncol 11, 1186\u20131193 (2025).","journal-title":"JAMA Oncol"},{"key":"1529_CR54","doi-asserted-by":"publisher","first-page":"j4849","DOI":"10.1136\/bmj.j4849","volume":"359","author":"C Ma","year":"2017","unstructured":"Ma, C. et al. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ 359, j4849 (2017).","journal-title":"BMJ"},{"key":"1529_CR55","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/oby.22936","volume":"28","author":"Look AHEAD Research Group; Yeh, H. -C. et al.","year":"2020","unstructured":"Look AHEAD Research Group; Yeh, H. -C. et al. Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the Look AHEAD randomized clinical trial. Obesity 28, 1678\u20131686 (2020).","journal-title":"Obesity"},{"key":"1529_CR56","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cmet.2018.09.022","volume":"29","author":"ET Cirulli","year":"2019","unstructured":"Cirulli, E. T. et al. Profound perturbation of the metabolome in obesity is associated with health risk. Cell Metab. 29, 488\u2013500 (2019).","journal-title":"Cell Metab."},{"key":"1529_CR57","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/s41366-021-00896-1","volume":"45","author":"LJ Goudswaard","year":"2021","unstructured":"Goudswaard, L. J. et al. Effects of adiposity on the human plasma proteome: observational and Mendelian randomisation estimates. Int. J. Obes. 45, 2221\u20132229 (2021).","journal-title":"Int. J. Obes."},{"key":"1529_CR58","first-page":"588","volume":"110","author":"SC Moore","year":"2018","unstructured":"Moore, S. C. et al. A metabolomics analysis of body mass index and postmenopausal breast cancer risk. J. Natl Cancer Inst. 110, 588\u2013597 (2018).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR59","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/jnci\/djad008","volume":"115","author":"M Sun","year":"2023","unstructured":"Sun, M. et al. Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study. J. Natl Cancer Inst. 115, 456\u2013467 (2023).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR60","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579\u2013591 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"1529_CR61","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","volume":"86","author":"ER Simpson","year":"2003","unstructured":"Simpson, E. R. Sources of estrogen and their importance. J. Steroid Biochem. Mol. Biol. 86, 225\u2013230 (2003).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1529_CR62","doi-asserted-by":"publisher","first-page":"e0187741","DOI":"10.1371\/journal.pone.0187741","volume":"12","author":"EL Watts","year":"2017","unstructured":"Watts, E. L. et al. Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men. PLoS ONE 12, e0187741 (2017).","journal-title":"PLoS ONE"},{"key":"1529_CR63","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/bjc.2011.254","volume":"105","author":"TJ Key","year":"2011","unstructured":"Key, T. J. et al. Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br. J. Cancer 105, 709\u2013722 (2011).","journal-title":"Br. J. Cancer"},{"key":"1529_CR64","doi-asserted-by":"crossref","unstructured":"Endogenous Hormones and Breast Cancer Collaborative Group; Key, T. J. et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 14, 1009\u20131019 (2013).","DOI":"10.1016\/S1470-2045(13)70301-2"},{"key":"1529_CR65","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00018-022-04562-1","volume":"79","author":"N Narinx","year":"2022","unstructured":"Narinx, N. et al. Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology. Cell. Mol. Life Sci. 79, 543 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"1529_CR66","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.tem.2015.05.001","volume":"26","author":"R Sim\u00f3","year":"2015","unstructured":"Sim\u00f3, R., S\u00e1ez-L\u00f3pez, C., Barbosa-Desongles, A., Hern\u00e1ndez, C. & Selva, D. M. Novel insights in SHBG regulation and clinical implications. Trends Endocrinol. Metab. 26, 376\u2013383 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"1529_CR67","doi-asserted-by":"publisher","first-page":"e467","DOI":"10.1210\/clinem\/dgab713","volume":"107","author":"SC Larsson","year":"2022","unstructured":"Larsson, S. C. et al. Serum estradiol and 20 site-specific cancers in women: Mendelian randomization study. J. Clin. Endocrinol. Metab. 107, e467\u2013e474 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1529_CR68","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ijc.11529","volume":"108","author":"A Lukanova","year":"2004","unstructured":"Lukanova, A. et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int. J. Cancer 108, 425\u2013432 (2004).","journal-title":"Int. J. Cancer"},{"key":"1529_CR69","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","volume":"385","author":"Collaborative Group On Epidemiological Studies Of Ovarian Cancer; Beral, V. et al.","year":"2015","unstructured":"Collaborative Group On Epidemiological Studies Of Ovarian Cancer; Beral, V. et al. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 385, 1835\u20131842 (2015).","journal-title":"Lancet"},{"key":"1529_CR70","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1158\/1055-9965.EPI-12-0310","volume":"21","author":"UA Hvidtfeldt","year":"2012","unstructured":"Hvidtfeldt, U. A. et al. Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer. Cancer Epidemiol. Biomarkers Prev. 21, 1203\u20131212 (2012).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1529_CR71","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1158\/1055-9965.EPI-20-0965","volume":"30","author":"SG Dashti","year":"2021","unstructured":"Dashti, S. G. et al. Adiposity and endometrial cancer risk in postmenopausal women: a sequential causal mediation analysis. Cancer Epidemiol. Biomarkers Prev. 30, 104\u2013113 (2021).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1529_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02322-3","volume":"20","author":"E Hazelwood","year":"2022","unstructured":"Hazelwood, E. et al. Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis. BMC Med. 20, 125 (2022).","journal-title":"BMC Med."},{"key":"1529_CR73","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1158\/0008-5472.CAN-16-3322","volume":"77","author":"J Ose","year":"2017","unstructured":"Ose, J. et al. Androgens are differentially associated with ovarian cancer subtypes in the ovarian cancer cohort consortium. Cancer Res. 77, 3951\u20133960 (2017).","journal-title":"Cancer Res."},{"key":"1529_CR74","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1677\/erc.1.01038","volume":"12","author":"R Kaaks","year":"2005","unstructured":"Kaaks, R. et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr. Relat. Cancer 12, 1071\u20131082 (2005).","journal-title":"Endocr. Relat. Cancer"},{"key":"1529_CR75","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","volume":"26","author":"KS Ruth","year":"2020","unstructured":"Ruth, K. S. et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat. Med. 26, 252\u2013258 (2020).","journal-title":"Nat. Med."},{"key":"1529_CR76","doi-asserted-by":"crossref","unstructured":"Perez-Cornago, A. et al. Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study. BMC Med. 15, 115 (2017).","DOI":"10.1186\/s12916-017-0876-7"},{"key":"1529_CR77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/aps.2014.18","volume":"36","author":"ME Tan","year":"2015","unstructured":"Tan, M. E., Li, J., Xu, H. E., Melcher, K. & Yong, E. Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol. Sin. 36, 3\u201323 (2015).","journal-title":"Acta Pharmacol. Sin."},{"key":"1529_CR78","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/ijc.34116","volume":"151","author":"EL Watts","year":"2022","unstructured":"Watts, E. L. et al. Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomisation analyses in international consortia. Int. J. Cancer 151, 1033\u20131046 (2022).","journal-title":"Int. J. Cancer"},{"key":"1529_CR79","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1215932","volume":"369","author":"IM Thompson","year":"2013","unstructured":"Thompson, I. M. et al. Long-term survival of participants in the prostate cancer prevention trial. N. Engl. J. Med. 369, 603\u2013610 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1529_CR80","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.eururo.2018.07.024","volume":"74","author":"EL Watts","year":"2018","unstructured":"Watts, E. L. et al. Low free testosterone and prostate cancer risk: a collaborative analysis of 20 prospective studies. Eur. Urol. 74, 585\u2013594 (2018).","journal-title":"Eur. Urol."},{"key":"1529_CR81","doi-asserted-by":"publisher","first-page":"111315","DOI":"10.1016\/j.biopha.2021.111315","volume":"137","author":"B Ahmed","year":"2021","unstructured":"Ahmed, B., Sultana, R. & Greene, M. W. Adipose tissue and insulin resistance in obese. Biomed. Pharmacother. Biomedecine Pharmacother. 137, 111315 (2021).","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"1529_CR82","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-020-0295-5","volume":"20","author":"EJ Gallagher","year":"2020","unstructured":"Gallagher, E. J. & LeRoith, D. Hyperinsulinaemia in cancer. Nat. Rev. Cancer 20, 629\u2013644 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1529_CR83","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1158\/1055-9965.EPI-20-1245","volume":"30","author":"J Pearson-Stuttard","year":"2021","unstructured":"Pearson-Stuttard, J. et al. Type 2 diabetes and cancer: an umbrella review of observational and Mendelian randomization studies. Cancer Epidemiol. Biomarkers Prev. 30, 1218\u20131228 (2021).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1529_CR84","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1007\/s00125-018-4664-5","volume":"61","author":"T Ohkuma","year":"2018","unstructured":"Ohkuma, T., Peters, S. A. E. & Woodward, M. Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events. Diabetologia 61, 2140\u20132154 (2018).","journal-title":"Diabetologia"},{"key":"1529_CR85","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/jnci\/djac011","volume":"114","author":"N Murphy","year":"2022","unstructured":"Murphy, N. et al. Associations between glycemic traits and colorectal cancer: a Mendelian randomization analysis. J. Natl Cancer Inst. 114, 740\u2013752 (2022).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR86","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/cam4.4434","volume":"11","author":"SG Dashti","year":"2022","unstructured":"Dashti, S. G. et al. Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol. Cancer Med. 11, 1145\u20131159 (2022).","journal-title":"Cancer Med."},{"key":"1529_CR87","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1002\/cncr.32444","volume":"125","author":"JL Petrick","year":"2019","unstructured":"Petrick, J. L. et al. Diabetes in relation to Barrett\u2019s esophagus and adenocarcinomas of the esophagus: a pooled study from the International Barrett\u2019s and Esophageal Adenocarcinoma Consortium. Cancer 125, 4210\u20134223 (2019).","journal-title":"Cancer"},{"key":"1529_CR88","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber, I. et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur. Urol. 84, 176\u2013190 (2023).","journal-title":"Eur. Urol."},{"key":"1529_CR89","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/ijc.29098","volume":"136","author":"A Hidaka","year":"2015","unstructured":"Hidaka, A. et al. Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer: the Japan Public Health Center-based prospective study. Int. J. Cancer 136, 1402\u20131410 (2015).","journal-title":"Int. J. Cancer"},{"key":"1529_CR90","doi-asserted-by":"publisher","first-page":"101946","DOI":"10.1016\/j.canep.2021.101946","volume":"73","author":"D Shi","year":"2021","unstructured":"Shi, D. et al. Diabetes increases the risk of meningioma: a systematic review and meta-analysis of observational studies. Cancer Epidemiol. 73, 101946 (2021).","journal-title":"Cancer Epidemiol."},{"key":"1529_CR91","doi-asserted-by":"publisher","first-page":"101245","DOI":"10.1016\/j.molmet.2021.101245","volume":"52","author":"D LeRoith","year":"2021","unstructured":"LeRoith, D., Holly, J. M. P. & Forbes, B. E. Insulin-like growth factors: ligands, binding proteins, and receptors. Mol. Metab. 52, 101245 (2021).","journal-title":"Mol. Metab."},{"key":"1529_CR92","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/ije\/dyac124","volume":"52","author":"EL Watts","year":"2023","unstructured":"Watts, E. L. et al. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis. Int. J. Epidemiol. 52, 71\u201386 (2023).","journal-title":"Int. J. Epidemiol."},{"key":"1529_CR93","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.annonc.2020.01.066","volume":"31","author":"N Murphy","year":"2020","unstructured":"Murphy, N. et al. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with \u223c430 000 women. Ann. Oncol. 31, 641\u2013649 (2020).","journal-title":"Ann. Oncol."},{"key":"1529_CR94","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1053\/j.gastro.2019.12.020","volume":"158","author":"N Murphy","year":"2020","unstructured":"Murphy, N. et al. Circulating levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 associate with risk of colorectal cancer based on serologic and Mendelian randomization analyses. Gastroenterology 158, 1300\u20131312 (2020).","journal-title":"Gastroenterology"},{"key":"1529_CR95","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1158\/0008-5472.CAN-20-1281","volume":"80","author":"A Knuppel","year":"2020","unstructured":"Knuppel, A. et al. Circulating insulin-like growth factor-I concentrations and risk of 30 cancers: prospective analyses in UK Biobank. Cancer Res. 80, 4014\u20134021 (2020).","journal-title":"Cancer Res."},{"key":"1529_CR96","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1002\/ijc.32276","volume":"145","author":"EL Watts","year":"2019","unstructured":"Watts, E. L. et al. The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies. Int. J. Cancer 145, 3244\u20133256 (2019).","journal-title":"Int. J. Cancer"},{"key":"1529_CR97","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s00125-012-2629-7","volume":"55","author":"V D\u2019Esposito","year":"2012","unstructured":"D\u2019Esposito, V. et al. Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro. Diabetologia 55, 2811\u20132822 (2012).","journal-title":"Diabetologia"},{"key":"1529_CR98","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","volume":"36","author":"M Fasshauer","year":"2015","unstructured":"Fasshauer, M. & Bl\u00fcher, M. Adipokines in health and disease. Trends Pharmacol. Sci. 36, 461\u2013470 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"1529_CR99","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/aje\/kwv041","volume":"182","author":"RZ Stolzenberg-Solomon","year":"2015","unstructured":"Stolzenberg-Solomon, R. Z. et al. Circulating leptin and risk of pancreatic cancer: a pooled analysis from 3 cohorts. Am. J. Epidemiol. 182, 187\u2013197 (2015).","journal-title":"Am. J. Epidemiol."},{"key":"1529_CR100","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-13-0258","volume":"22","author":"P Luhn","year":"2013","unstructured":"Luhn, P. et al. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol. Biomarkers Prev. 22, 1304\u20131312 (2013).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1529_CR101","doi-asserted-by":"publisher","first-page":"103177","DOI":"10.1016\/j.critrevonc.2020.103177","volume":"157","author":"N Michels","year":"2021","unstructured":"Michels, N., van Aart, C., Morisse, J., Mullee, A. & Huybrechts, I. Chronic inflammation towards cancer incidence: a systematic review and meta-analysis of epidemiological studies. Crit. Rev. Oncol. Hematol. 157, 103177 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1529_CR102","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrc3967","volume":"15","author":"AG Renehan","year":"2015","unstructured":"Renehan, A. G., Zwahlen, M. & Egger, M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat. Rev. Cancer 15, 484\u2013498 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"1529_CR103","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/ijc.33338","volume":"148","author":"NL Dimou","year":"2021","unstructured":"Dimou, N. L. et al. Circulating adipokine concentrations and risk of five obesity-related cancers: a Mendelian randomization study. Int. J. Cancer 148, 1625\u20131636 (2021).","journal-title":"Int. J. Cancer"},{"key":"1529_CR104","doi-asserted-by":"publisher","first-page":"658913","DOI":"10.1155\/2014\/658913","volume":"2014","author":"E Nigro","year":"2014","unstructured":"Nigro, E. et al. New insight into adiponectin role in obesity and obesity-related diseases. Biomed. Res. Int. 2014, 658913 (2014).","journal-title":"Biomed. Res. Int."},{"key":"1529_CR105","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1158\/0008-5472.CAN-11-2771","volume":"72","author":"GYF Ho","year":"2012","unstructured":"Ho, G. Y. F. et al. Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res. 72, 3029\u20133037 (2012).","journal-title":"Cancer Res."},{"key":"1529_CR106","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1158\/1940-6207.CAPR-13-0169","volume":"6","author":"M Song","year":"2013","unstructured":"Song, M. et al. Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study. Cancer Prev. Res. 6, 875\u2013885 (2013).","journal-title":"Cancer Prev. Res."},{"key":"1529_CR107","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/jnci\/djs474","volume":"105","author":"Y Bao","year":"2013","unstructured":"Bao, Y. et al. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J. Natl Cancer Inst. 105, 95\u2013103 (2013).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR108","first-page":"801","volume":"28","author":"LM Liao","year":"2017","unstructured":"Liao, L. M. et al. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial. Cancer Causes Control 28, 801\u2013807 (2017).","journal-title":"Cancer Causes Control"},{"key":"1529_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajog.2010.08.045","volume":"204","author":"PT Soliman","year":"2011","unstructured":"Soliman, P. T., Cui, X., Zhang, Q., Hankinson, S. E. & Lu, K. H. Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses\u2019 Health Study. Am. J. Obstet. Gynecol. 204, 1\u20135 (2011).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1529_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02506-x","volume":"20","author":"M Zhu","year":"2022","unstructured":"Zhu, M. et al. C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis. BMC Med. 20, 301 (2022).","journal-title":"BMC Med."},{"key":"1529_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02193-0","volume":"20","author":"E Bouras","year":"2022","unstructured":"Bouras, E. et al. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 20, 3 (2022).","journal-title":"BMC Med."},{"key":"1529_CR112","doi-asserted-by":"publisher","first-page":"104991","DOI":"10.1016\/j.ebiom.2024.104991","volume":"100","author":"J Yarmolinsky","year":"2024","unstructured":"Yarmolinsky, J. et al. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. EBioMedicine 100, 104991 (2024).","journal-title":"EBioMedicine"},{"key":"1529_CR113","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJM199602013340503","volume":"334","author":"RV Considine","year":"1996","unstructured":"Considine, R. V. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292\u2013295 (1996).","journal-title":"N. Engl. J. Med."},{"key":"1529_CR114","doi-asserted-by":"publisher","first-page":"dju294","DOI":"10.1093\/jnci\/dju294","volume":"106","author":"MS Shiels","year":"2014","unstructured":"Shiels, M. S. et al. Cigarette smoking and variations in systemic immune and inflammation markers. J. Natl Cancer Inst. 106, dju294 (2014).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR115","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41574-018-0126-x","volume":"15","author":"DF Quail","year":"2019","unstructured":"Quail, D. F. & Dannenberg, A. J. The obese adipose tissue microenvironment in cancer development and progression. Nat. Rev. Endocrinol. 15, 139\u2013154 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1529_CR116","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","volume":"34","author":"NM Iyengar","year":"2016","unstructured":"Iyengar, N. M., Gucalp, A., Dannenberg, A. J. & Hudis, C. A. Obesity and cancer mechanisms: tumor microenvironment and inflammation. J. Clin. Oncol. 34, 4270\u20134276 (2016).","journal-title":"J. Clin. Oncol."},{"key":"1529_CR117","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.trecan.2018.03.004","volume":"4","author":"E Lengyel","year":"2018","unstructured":"Lengyel, E., Makowski, L., DiGiovanni, J. & Kolonin, M. G. Cancer as a matter of fat: the crosstalk between adipose tissue and tumors. Trends Cancer 4, 374\u2013384 (2018).","journal-title":"Trends Cancer"},{"key":"1529_CR118","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.cmet.2017.09.018","volume":"26","author":"M Rios Garcia","year":"2017","unstructured":"Rios Garcia, M. et al. Acetyl-CoA carboxylase 1-dependent protein acetylation controls breast cancer metastasis and recurrence. Cell Metab. 26, 842\u2013855 (2017).","journal-title":"Cell Metab."},{"key":"1529_CR119","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren, J., Bergstr\u00f6m, R., Lindgren, A. & Nyr\u00e9n, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340, 825\u2013831 (1999).","journal-title":"N. Engl. J. Med."},{"key":"1529_CR120","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","volume":"143","author":"H Hampel","year":"2005","unstructured":"Hampel, H., Abraham, N. S. & El-Serag, H. B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann. Intern. Med. 143, 199\u2013211 (2005).","journal-title":"Ann. Intern. Med."},{"key":"1529_CR121","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41416-018-0356-7","volume":"120","author":"JAA van de Pol","year":"2019","unstructured":"van de Pol, J. A. A., van den Brandt, P. A. & Schouten, L. J. Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands Cohort Study. Br. J. Cancer 120, 368\u2013374 (2019).","journal-title":"Br. J. Cancer"},{"key":"1529_CR122","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/qjmed\/hcu195","volume":"108","author":"W Cheungpasitporn","year":"2015","unstructured":"Cheungpasitporn, W. et al. The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. QJM 108, 205\u2013212 (2015).","journal-title":"QJM"},{"key":"1529_CR123","first-page":"17","volume":"22","author":"W Poore","year":"2020","unstructured":"Poore, W. et al. Obesity and its impact on kidney stone formation. Rev. Urol. 22, 17\u201323 (2020).","journal-title":"Rev. Urol."},{"key":"1529_CR124","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJM200011023431804","volume":"343","author":"WH Chow","year":"2000","unstructured":"Chow, W. H., Gridley, G., Fraumeni, J. F. & J\u00e4rvholm, B. Obesity, hypertension, and the risk of kidney cancer in men. N. Engl. J. Med. 343, 1305\u20131311 (2000).","journal-title":"N. Engl. J. Med."},{"key":"1529_CR125","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","volume":"6","author":"LM Stinton","year":"2012","unstructured":"Stinton, L. M. & Shaffer, E. A. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 6, 172\u2013187 (2012).","journal-title":"Gut Liver"},{"key":"1529_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-12-45","volume":"12","author":"GK Reeves","year":"2014","unstructured":"Reeves, G. K. et al. Hospital admissions in relation to body mass index in UK women: a prospective cohort study. BMC Med. 12, 45 (2014).","journal-title":"BMC Med."},{"key":"1529_CR127","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/hep.31537","volume":"73","author":"C Barahona Ponce","year":"2021","unstructured":"Barahona Ponce, C. et al. Gallstones, body mass index, c-reactive protein, and gallbladder cancer: Mendelian randomization analysis of Chilean and European genotype data. Hepatology 73, 1783\u20131796 (2021).","journal-title":"Hepatology"},{"key":"1529_CR128","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","volume":"155","author":"F Kanwal","year":"2018","unstructured":"Kanwal, F. et al. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology 155, 1828\u20131837 (2018).","journal-title":"Gastroenterology"},{"key":"1529_CR129","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S2468-1253(23)00275-3","volume":"9","author":"JA Thomas","year":"2024","unstructured":"Thomas, J. A., Kendall, B. J., El-Serag, H. B., Thrift, A. P. & Macdonald, G. A. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease. Lancet Gastroenterol. Hepatol. 9, 159\u2013169 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1529_CR130","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ajg.2017.218","volume":"112","author":"J Kirkeg\u00e5rd","year":"2017","unstructured":"Kirkeg\u00e5rd, J., Mortensen, F. V. & Cronin-Fenton, D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis. Am. J. Gastroenterol. 112, 1366\u20131372 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"1529_CR131","doi-asserted-by":"publisher","first-page":"dgz059","DOI":"10.1210\/clinem\/dgz059","volume":"105","author":"SEJ Hansen","year":"2020","unstructured":"Hansen, S. E. J., Madsen, C. M., Varbo, A. & Nordestgaard, B. G. Body mass index, triglycerides, and risk of acute pancreatitis: a population-based study of 118,000 individuals. J. Clin. Endocrinol. Metab. 105, dgz059 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1529_CR132","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jnci\/djj004","volume":"98","author":"KE Smedby","year":"2006","unstructured":"Smedby, K. E. et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J. Natl Cancer Inst. 98, 51\u201360 (2006).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR133","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1136\/annrheumdis-2014-205459","volume":"73","author":"B Lu","year":"2014","unstructured":"Lu, B. et al. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study. Ann. Rheum. Dis. 73, 1914\u20131922 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1529_CR134","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/metabo11020095","volume":"11","author":"SC Moore","year":"2021","unstructured":"Moore, S. C. et al. A metabolomics analysis of postmenopausal breast cancer risk in the cancer prevention study II. Metabolites 11, 95 (2021).","journal-title":"Metabolites"},{"key":"1529_CR135","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13058-023-01602-x","volume":"25","author":"VL Stevens","year":"2023","unstructured":"Stevens, V. L. et al. A prospective case-cohort analysis of plasma metabolites and breast cancer risk. Breast Cancer Res. 25, 5 (2023).","journal-title":"Breast Cancer Res."},{"key":"1529_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1408-4","volume":"17","author":"M His","year":"2019","unstructured":"His, M. et al. Prospective analysis of circulating metabolites and breast cancer in EPIC. BMC Med. 17, 178 (2019).","journal-title":"BMC Med."},{"key":"1529_CR137","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1158\/1055-9965.EPI-19-0154","volume":"28","author":"L L\u00e9cuyer","year":"2019","unstructured":"L\u00e9cuyer, L. et al. Plasma metabolomic signatures associated with long-term breast cancer risk in the SU.VI.MAX prospective cohort. Cancer Epidemiol. Biomarkers Prev. 28, 1300\u20131307 (2019).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1529_CR138","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/s41416-021-01304-1","volume":"124","author":"E Jobard","year":"2021","unstructured":"Jobard, E. et al. Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case-control study nested within the French E3N cohort. Br. J. Cancer 124, 1734\u20131743 (2021).","journal-title":"Br. J. Cancer"},{"key":"1529_CR139","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/oby.22670","volume":"28","author":"VL Stevens","year":"2020","unstructured":"Stevens, V. L., Carter, B. D., McCullough, M. L., Campbell, P. T. & Wang, Y. Metabolomic profiles associated with BMI, waist circumference, and diabetes and inflammation biomarkers in women. Obesity 28, 187\u2013196 (2020).","journal-title":"Obesity"},{"key":"1529_CR140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003786","volume":"18","author":"F Guida","year":"2021","unstructured":"Guida, F. et al. The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium. PLoS Med. 18, e1003786 (2021).","journal-title":"PLoS Med."},{"key":"1529_CR141","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3390\/metabo12121189","volume":"12","author":"KM McClain","year":"2022","unstructured":"McClain, K. M. et al. Metabolomic analysis of renal cell carcinoma in the prostate, lung, colorectal, and ovarian cancer screening trial. Metabolites 12, 1189 (2022).","journal-title":"Metabolites"},{"key":"1529_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02553-4","volume":"20","author":"M Breeur","year":"2022","unstructured":"Breeur, M. et al. Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 20, 351 (2022).","journal-title":"BMC Med."},{"key":"1529_CR143","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-01970-1","volume":"19","author":"N Kliemann","year":"2021","unstructured":"Kliemann, N. et al. Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 19, 101 (2021).","journal-title":"BMC Med."},{"key":"1529_CR144","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/metabo10030099","volume":"10","author":"BA Dickerman","year":"2020","unstructured":"Dickerman, B. A. et al. A metabolomics analysis of adiposity and advanced prostate cancer risk in the health professionals follow-up study. Metabolites 10, 99 (2020).","journal-title":"Metabolites"},{"key":"1529_CR145","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41416-022-01873-9","volume":"127","author":"KD Brantley","year":"2022","unstructured":"Brantley, K. D. et al. A metabolomic analysis of adiposity measures and pre- and postmenopausal breast cancer risk in the Nurses\u2019 Health Studies. Br. J. Cancer 127, 1076\u20131085 (2022).","journal-title":"Br. J. Cancer"},{"key":"1529_CR146","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/metabo13020234","volume":"13","author":"M Yang","year":"2023","unstructured":"Yang, M. et al. A metabolomic signature of obesity and risk of colorectal cancer: two nested case-control studies. Metabolites 13, 234 (2023).","journal-title":"Metabolites"},{"key":"1529_CR147","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s10654-023-01038-9","volume":"38","author":"P Yao","year":"2023","unstructured":"Yao, P. et al. Conventional and genetic associations of adiposity with 1463 proteins in relatively lean Chinese adults. Eur. J. Epidemiol. 38, 1089\u20131103 (2023).","journal-title":"Eur. J. Epidemiol."},{"key":"1529_CR148","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn, G. H. et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622, 348\u2013358 (2023).","journal-title":"Nature"},{"key":"1529_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43485-8","volume":"14","author":"A M\u00e4larstig","year":"2023","unstructured":"M\u00e4larstig, A. et al. Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation. Nat. Commun. 14, 7680 (2023).","journal-title":"Nat. Commun."},{"key":"1529_CR150","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1158\/1055-9965.EPI-25-0165","volume":"34","author":"SE Wang","year":"2025","unstructured":"Wang, S. E. et al. The effect of circulating proteins and their role in mediating adiposity\u2019s effect on endometrial cancer risk: Mendelian randomisation and colocalization analyses. Cancer Epidemiol. Biomarkers Prev. 34, 1534\u20131543 (2025).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1529_CR151","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/JS9.0000000000003474","volume":"112","author":"W Liu","year":"2025","unstructured":"Liu, W., Chen, W., Dong, D., Zhang, G. & Xing, N. Pre-diagnostic plasma proteomics profile uncovers new biomarkers and mechanistic insights for incident kidney cancer. Int. J. Surg. 112, 873\u2013886 (2025).","journal-title":"Int. J. Surg."},{"key":"1529_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-02214-3","volume":"28","author":"MI Marchal","year":"2026","unstructured":"Marchal, M. I. et al. Distinct genetic profiles of obesity have different effects on breast cancer risk: leveraging Mendelian randomisation to interrogate causal pathways and identify mediating proteins. Breast Cancer Res. 28, 23 (2026).","journal-title":"Breast Cancer Res."},{"key":"1529_CR153","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41591-024-03355-2","volume":"31","author":"L Maretty","year":"2025","unstructured":"Maretty, L. et al. Proteomic changes upon treatment with semaglutide in individuals with obesity. Nat. Med. 31, 267\u2013277 (2025).","journal-title":"Nat. Med."},{"key":"1529_CR154","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/ATVBAHA.118.311928","volume":"39","author":"RV Shah","year":"2019","unstructured":"Shah, R. V. et al. Proteins altered by surgical weight loss highlight biomarkers of insulin resistance in the community. Arterioscler. Thromb. Vasc. Biol. 39, 107\u2013115 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1529_CR155","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","volume":"365","author":"P Sumithran","year":"2011","unstructured":"Sumithran, P. et al. Long-term persistence of hormonal adaptations to weight loss. N. Engl. J. Med. 365, 1597\u20131604 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1529_CR156","doi-asserted-by":"crossref","unstructured":"Bull, C. J. et al. Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes. EBioMedicine 100, 104977 (2024).","DOI":"10.1016\/j.ebiom.2024.104977"},{"key":"1529_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0303-2","volume":"8","author":"CL Boulang\u00e9","year":"2016","unstructured":"Boulang\u00e9, C. L., Neves, A. L., Chilloux, J., Nicholson, J. K. & Dumas, M. -E. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 8, 42 (2016).","journal-title":"Genome Med."},{"key":"1529_CR158","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db07-1403","volume":"57","author":"PD Cani","year":"2008","unstructured":"Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470\u20131481 (2008).","journal-title":"Diabetes"},{"key":"1529_CR159","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","volume":"103","author":"JM Baker","year":"2017","unstructured":"Baker, J. M., Al-Nakkash, L. & Herbst-Kralovetz, M. M. Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas 103, 45\u201353 (2017).","journal-title":"Maturitas"},{"key":"1529_CR160","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A Agus","year":"2021","unstructured":"Agus, A., Cl\u00e9ment, K. & Sokol, H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 70, 1174\u20131182 (2021).","journal-title":"Gut"},{"key":"1529_CR161","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/epirev\/mxt010","volume":"36","author":"MF Munsell","year":"2014","unstructured":"Munsell, M. F., Sprague, B. L., Berry, D. A., Chisholm, G. & Trentham-Dietz, A. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol. Rev. 36, 114\u2013136 (2014).","journal-title":"Epidemiol. Rev."},{"key":"1529_CR162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001200","volume":"9","author":"Collaborative Group on Epidemiological Studies of Ovarian Cancer.","year":"2012","unstructured":"Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med. 9, e1001200 (2012).","journal-title":"PLoS Med."},{"key":"1529_CR163","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1158\/1055-9965.EPI-10-0832","volume":"19","author":"EJ Crosbie","year":"2010","unstructured":"Crosbie, E. J., Zwahlen, M., Kitchener, H. C., Egger, M. & Renehan, A. G. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 19, 3119\u20133130 (2010).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1529_CR164","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/ije\/dys176","volume":"41","author":"C Hoyo","year":"2012","unstructured":"Hoyo, C. et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int. J. Epidemiol. 41, 1706\u20131718 (2012).","journal-title":"Int. J. Epidemiol."},{"key":"1529_CR165","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.48447","volume":"5","author":"X Chen","year":"2022","unstructured":"Chen, X., Li, H., Mandic, M., Hoffmeister, M. & Brenner, H. Assessment of body mass index, polygenic risk score, and development of colorectal cancer. JAMA Netw. Open 5, e2248447 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1529_CR166","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/jnci\/djaa056","volume":"113","author":"PM Kapoor","year":"2021","unstructured":"Kapoor, P. M. et al. Combined associations of a polygenic risk score and classical risk factors with breast cancer risk. J. Natl Cancer Inst. 113, 329\u2013337 (2021).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR167","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/jnci\/djaa058","volume":"113","author":"PT Campbell","year":"2020","unstructured":"Campbell, P. T. et al. Association of body mass index with colorectal cancer risk by genome-wide variants. J. Natl Cancer Inst. 113, 38\u201347 (2020).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR168","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1158\/0008-5472.CAN-22-3713","volume":"83","author":"EK Aglago","year":"2023","unstructured":"Aglago, E. K. et al. A genetic locus within the FMN1\/GREM1 gene region interacts with body mass index in colorectal cancer risk. Cancer Res. 83, 2572\u20132583 (2023).","journal-title":"Cancer Res."},{"key":"1529_CR169","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3748\/wjg.v12.i3.354","volume":"12","author":"KD Crew","year":"2006","unstructured":"Crew, K. D. & Neugut, A. I. Epidemiology of gastric cancer. World J. Gastroenterol. 12, 354\u2013362 (2006).","journal-title":"World J. Gastroenterol."},{"key":"1529_CR170","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","volume":"154","author":"CC Abnet","year":"2018","unstructured":"Abnet, C. C., Arnold, M. & Wei, W. -Q. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 154, 360\u2013373 (2018).","journal-title":"Gastroenterology"},{"key":"1529_CR171","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/ijc.33292","volume":"148","author":"W Zhou","year":"2021","unstructured":"Zhou, W. et al. Causal relationships between body mass index, smoking and lung cancer: univariable and multivariable Mendelian randomization. Int. J. Cancer 148, 1077\u20131086 (2021).","journal-title":"Int. J. Cancer"},{"key":"1529_CR172","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/jnci\/djx286","volume":"110","author":"D Yu","year":"2018","unstructured":"Yu, D. et al. Overall and central obesity and risk of lung cancer: a pooled analysis. J. Natl Cancer Inst. 110, 831\u2013842 (2018).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105010","volume":"101","author":"N Papadimitriou","year":"2024","unstructured":"Papadimitriou, N. et al. Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses. EBioMedicine 101, 105010 (2024).","journal-title":"EBioMedicine"},{"key":"1529_CR174","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/jnci\/djac215","volume":"115","author":"N Murphy","year":"2023","unstructured":"Murphy, N. et al. Body mass ind ex and molecular subtypes of colorectal cancer. J. Natl Cancer Inst. 115, 165\u2013173 (2023).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR175","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/s41588-024-01969-3","volume":"56","author":"C Tang","year":"2024","unstructured":"Tang, C. et al. Obesity-dependent selection of driver mutations in cancer. Nat. Genet. 56, 2318\u20132321 (2024).","journal-title":"Nat. Genet."},{"key":"1529_CR176","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61082","volume":"10","author":"B Afsari","year":"2021","unstructured":"Afsari, B. et al. Supervised mutational signatures for obesity and other tissue-specific etiological factors in cancer. eLife 10, e61082 (2021).","journal-title":"eLife"},{"key":"1529_CR177","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","volume":"75","author":"R Pinyol","year":"2021","unstructured":"Pinyol, R. et al. Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J. Hepatol. 75, 865\u2013878 (2021).","journal-title":"J. Hepatol."},{"key":"1529_CR178","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker, D. J. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 27, 740\u2013756 (2018).","journal-title":"Cell Metab."},{"key":"1529_CR179","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s10654-019-00587-2","volume":"34","author":"S-M Jeong","year":"2019","unstructured":"Jeong, S. -M., Lee, D. H. & Giovannucci, E. L. Predicted lean body mass, fat mass and risk of lung cancer incidence: prospective US cohort study. Eur. J. Epidemiol. 34, 1151\u20131160 (2019).","journal-title":"Eur. J. Epidemiol."},{"key":"1529_CR180","doi-asserted-by":"publisher","first-page":"101391","DOI":"10.1016\/j.xcrm.2023.101391","volume":"5","author":"H Yamazaki","year":"2024","unstructured":"Yamazaki, H. et al. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: a prospective cohort and Mendelian randomization study. Cell Rep. Med. 5, 101391 (2024).","journal-title":"Cell Rep. Med."},{"key":"1529_CR181","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1158\/1055-9965.EPI-24-1267","volume":"34","author":"R Peila","year":"2025","unstructured":"Peila, R. & Rohan, T. E. MRI measures of fat distribution and risk of cancer. Cancer Epidemiol. Biomarkers Prev. 34, 534\u2013540 (2025).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1529_CR182","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1093\/jnci\/djaf201","volume":"117","author":"E Hazelwood","year":"2025","unstructured":"Hazelwood, E. et al. Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis. J. Natl Cancer Inst. 117, 2621\u20132642 (2025).","journal-title":"J. Natl Cancer Inst."},{"key":"1529_CR183","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s42255-021-00346-2","volume":"3","author":"LO Huang","year":"2021","unstructured":"Huang, L. O. et al. Genome-wide discovery of genetic loci that uncouple excess adiposity from its comorbidities. Nat. Metab. 3, 228\u2013243 (2021).","journal-title":"Nat. Metab."},{"key":"1529_CR184","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04124-9","volume":"9","author":"TW Winkler","year":"2018","unstructured":"Winkler, T. W. et al. A joint view on genetic variants for adiposity differentiates subtypes with distinct metabolic implications. Nat. Commun. 9, 1946 (2018).","journal-title":"Nat. Commun."},{"key":"1529_CR185","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/ije\/dyaa062","volume":"49","author":"Z Kutalik","year":"2020","unstructured":"Kutalik, Z. Commentary on: \u201cThe contribution of tissue-specific BMI-associated gene sets to cardiometabolic disease risk: a Mendelian randomization study. Int. J. Epidemiol. 49, 1257\u20131258 (2020).","journal-title":"Int. J. Epidemiol."},{"key":"1529_CR186","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/biostatistics\/kxae006","volume":"25","author":"J Jin","year":"2024","unstructured":"Jin, J., Qi, G., Yu, Z. & Chatterjee, N. Mendelian randomization analysis using multiple biomarkers of an underlying common exposure. Biostatistics 25, 1015\u20131033 (2024).","journal-title":"Biostatistics"},{"key":"1529_CR187","doi-asserted-by":"crossref","unstructured":"Agrawal, S. et al. BMI-adjusted adipose tissue volumes exhibit depot-specific and divergent associations with cardiometabolic diseases. Nat. Commun. 14, 266 (2023).","DOI":"10.1038\/s41467-022-35704-5"},{"key":"1529_CR188","doi-asserted-by":"publisher","unstructured":"Kim, M. S. et al. Genomics reveals eleven obesity endotypes with distinct biological and phenotypic signatures. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2025.06.30.25330607 (2025).","DOI":"10.1101\/2025.06.30.25330607"},{"key":"1529_CR189","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-5573-4-4","volume":"4","author":"SW Marshall","year":"2007","unstructured":"Marshall, S. W. Power for tests of interaction: effect of raising the type I error rate. Epidemiol. Perspect. Innov. 4, 4 (2007).","journal-title":"Epidemiol. Perspect. Innov."},{"key":"1529_CR190","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/ije\/dyw127","volume":"45","author":"DA Lawlor","year":"2016","unstructured":"Lawlor, D. A., Tilling, K. & Davey Smith, G. Triangulation in aetiological epidemiology. Int. J. Epidemiol. 45, 1866\u20131886 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"1529_CR191","unstructured":"OpenSAFELY: Home. https:\/\/www.opensafely.org\/"},{"key":"1529_CR192","unstructured":"Our Future Health. Our Future Health https:\/\/ourfuturehealth.org.uk\/"},{"key":"1529_CR193","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S1470-2045(15)00218-1","volume":"16","author":"K Strasser-Weippl","year":"2015","unstructured":"Strasser-Weippl, K. et al. Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol. 16, 1405\u20131438 (2015).","journal-title":"Lancet Oncol."},{"key":"1529_CR194","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/S1470-2045(18)30019-6","volume":"19","author":"A Znaor","year":"2018","unstructured":"Znaor, A. et al. Cancer surveillance in northern Africa, and central and western Asia: challenges and strategies in support of developing cancer registries. Lancet Oncol. 19, e85\u2013e92 (2018).","journal-title":"Lancet Oncol."},{"key":"1529_CR195","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/S1470-2045(21)00720-8","volume":"23","author":"W Ngwa","year":"2022","unstructured":"Ngwa, W. et al. Cancer in sub-Saharan Africa: a Lancet Oncology Commission. Lancet Oncol. 23, e251\u2013e312 (2022).","journal-title":"Lancet Oncol."},{"key":"1529_CR196","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/s41588-024-01891-8","volume":"56","author":"A Herms","year":"2024","unstructured":"Herms, A. et al. Organismal metabolism regulates the expansion of oncogenic PIK3CA mutant clones in normal esophagus. Nat. Genet. 56, 2144\u20132157 (2024).","journal-title":"Nat. Genet."},{"key":"1529_CR197","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41366-021-01027-6","volume":"46","author":"A Naqvi","year":"2022","unstructured":"Naqvi, A. et al. The impact of obesity and bariatric surgery on the immune microenvironment of the endometrium. Int. J. Obes. 46, 605\u2013612 (2022).","journal-title":"Int. J. Obes."},{"key":"1529_CR198","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1002\/oby.21984","volume":"25","author":"RJ Beeken","year":"2017","unstructured":"Beeken, R. J. et al. The impact of diet-induced weight loss on biomarkers for colorectal cancer: an exploratory study (INTERCEPT). Obesity 25, S95\u2013S101 (2017).","journal-title":"Obesity"},{"key":"1529_CR199","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-025-09233-2","volume":"644","author":"M Ama","year":"2025","unstructured":"Ama, M. et al. Selective remodelling of the adipose niche in obesity and weight loss. Nature 644, 769\u2013779 (2025).","journal-title":"Nature"},{"key":"1529_CR200","unstructured":"World Health Organization. Report of the Commission on Ending Childhood Obesity: implementation plan: executive summary. WHO https:\/\/apps.who.int\/iris\/handle\/10665\/259349 (2017)."},{"key":"1529_CR201","doi-asserted-by":"publisher","first-page":"102441","DOI":"10.1016\/j.foodpol.2023.102441","volume":"117","author":"J Cawley","year":"2023","unstructured":"Cawley, J. & Frisvold, D. Review: Taxes on sugar-sweetened beverages: political economy, and effects on prices, purchases, and consumption. Food Policy 117, 102441 (2023).","journal-title":"Food Policy"},{"key":"1529_CR202","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1016\/S2214-109X(16)30217-0","volume":"4","author":"I Kickbusch","year":"2016","unstructured":"Kickbusch, I., Allen, L. & Franz, C. The commercial determinants of health. Lancet Glob. Health 4, e895\u2013e896 (2016).","journal-title":"Lancet Glob. Health"},{"key":"1529_CR203","doi-asserted-by":"publisher","first-page":"100127","DOI":"10.1016\/j.obpill.2024.100127","volume":"12","author":"W Ghusn","year":"2024","unstructured":"Ghusn, W. & Hurtado, M. D. Glucagon-like Receptor-1 agonists for obesity: weight loss outcomes, tolerability, side effects, and risks. Obes. Pillars 12, 100127 (2024).","journal-title":"Obes. Pillars"},{"key":"1529_CR204","doi-asserted-by":"publisher","first-page":"e2457349","DOI":"10.1001\/jamanetworkopen.2024.57349","volume":"8","author":"PJ Rodriguez","year":"2025","unstructured":"Rodriguez, P. J. et al. Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity. JAMA Netw. Open 8, e2457349 (2025).","journal-title":"JAMA Netw. Open"},{"key":"1529_CR205","doi-asserted-by":"crossref","unstructured":"Blood proteins predict the risk of many diseases years before onset. Nat. Med. 30, 2419\u20132420 (2024).","DOI":"10.1038\/s41591-024-03145-w"},{"key":"1529_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43575-7","volume":"14","author":"J You","year":"2023","unstructured":"You, J. et al. Plasma proteomic profiles predict individual future health risk. Nat. Commun. 14, 7817 (2023).","journal-title":"Nat. Commun."},{"key":"1529_CR207","doi-asserted-by":"publisher","unstructured":"Kundu, P., Burgess, S. & Chatterjee, N. Estimating burden of mortality due to excess body mass index in the US adult population by combining evidence from a Mendelian randomization study and national health surveys. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2023.03.17.23287394 (2023).","DOI":"10.1101\/2023.03.17.23287394"},{"key":"1529_CR208","unstructured":"Institute for Health Metrics and Evaluation. Global Burden of Disease results. IHME https:\/\/www.healthdata.org\/data-tools-practices\/interactive-visuals\/gbd-results (2025)."},{"key":"1529_CR209","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","volume":"51","author":"RM Baron","year":"1986","unstructured":"Baron, R. M. & Kenny, D. A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 51, 1173\u20131182 (1986).","journal-title":"J. Pers. Soc. Psychol."},{"key":"1529_CR210","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/ije\/dyt127","volume":"42","author":"L Richiardi","year":"2013","unstructured":"Richiardi, L., Bellocco, R. & Zugna, D. Mediation analysis in epidemiology: methods, interpretation and bias. Int. J. Epidemiol. 42, 1511\u20131519 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"1529_CR211","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/em-2012-0010","volume":"2","author":"TJ VanderWeele","year":"2014","unstructured":"VanderWeele, T. J. & Vansteelandt, S. Mediation analysis with multiple mediators. Epidemiol. Methods 2, 95\u2013115 (2014).","journal-title":"Epidemiol. Methods"},{"key":"1529_CR212","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter, A. R. et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur. J. Epidemiol. 36, 465\u2013478 (2021).","journal-title":"Eur. J. Epidemiol."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01529-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01529-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01529-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:02:41Z","timestamp":1782396161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01529-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":212,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1529"],"URL":"https:\/\/doi.org\/10.1038\/s42255-026-01529-5","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}